How Linking Real-World Data Sources Can Unlock the Patient Journey

Biotech, Clinical Trials, Commercialization & HEOR, Drug Discovery & Development, Life Science, Pharma,
  • Tuesday, October 28, 2025 | 1pm EDT (NA) / 5pm GMT (UK) / 6pm CET (EU-Central)
  • 60 min

Real-world data (RWD) often lacks the depth required to uncover complete patient journeys. Understanding a patient’s history, comorbidities, treatments and outcomes typically requires integration across disparate datasets, including claims, electronic health records (EHRs), images and genomic data. But which data sources are worth the investment, and what’s the actual value of linking them?

This webinar will explore various RWD sources, including the benefits and limitations of each source when leveraged by life sciences organizations – from clinical development to commercialization. The discussion will focus on evaluating data sources and the advantages of linking them for different use cases to support data-driven business decisions.

This webinar is part of the RWD in Action Series and will feature a discussion that includes:

  • Evaluation of benefits and challenges of leveraging various RWD sources such as EHRs, images, claims and genomic data
  • The process and value of linking RWD sources to drive decision making across the drug development lifecycle
  • Case studies utilizing data linked from multiple RWD sources

Register for this webinar to learn how linking real-world data sources can support data-driven decision-making across the drug development lifecycle.

Speakers

Dr Sarah Matt,

Dr. Sarah Matt, Physician, Health Tech Strategist & Author, (No company)

Dr. Sarah Matt is a Physician and Health Tech Strategist who advises startups, investors and global organizations on how to turn ambitious ideas into scalable healthcare solutions. Most recently, she served as Chief Strategy Officer at Sovato, a medtech company focused on remote robotic surgery, where she led early commercialization, reimbursement strategy and partnership development across device manufacturers and clinical organizations.

Sarah has held multiple Vice President roles in leading healthcare technology companies. At Oracle, she built the Healthcare and Life Sciences business for Oracle Cloud Infrastructure and helped shape the company’s direction during the $28 billion acquisition of Cerner. She led cross-functional teams across product, clinical and go-to-market, driving strategic alignment and growth. Her earlier roles at ESO and NextGen focused on scaling products across EHR, emergency response and population health.

Sarah teaches at SUNY Upstate Medical University and is the author of The Borderless Healthcare Revolution (Wiley, Fall 2025), which explores how technology is transforming access to care around the world. Her work focuses on making real-world data usable and meaningful across clinical, operational and regulatory settings.

Message Presenter
Praveen Haridas, Amazon Web Services

Praveen Haridas, World Wide Lead - HCLS Real World Data & Solutions, Amazon Web Services

Praveen is the Worldwide Lead of AWS Real World Strategy and Applications. Over his 19+ year professional career, he has driven strategy, market development and product launches for data and technology transformations in the Healthcare and Life Sciences industries. He has helped scale products from pre-revenue to multi-million-dollar solutions by collaborating with the global healthcare data ecosystem, including health systems, health plans, ISVs and Life Sciences Organizations. Prior to joining AWS in 2020, Praveen spent 14+ years as a healthcare and life sciences consulting leader at Accenture and Deloitte Consulting.

Message Presenter
Mike D’Ambrosio, Parexel International

Mike D’Ambrosio, SVP, Global Head Real World Research (RWD/RWE), Parexel International

Mike D’Ambrosio has 22 years of industry experience at the top 5 CRO, including in RWE/RWD general manager roles, leading RWE/RWD and Medical Affairs cross-functional teams (operations, consultancy, epidemiology, health economics and outcomes research and data sciences). He has preclinical, clinical, real-world research and consultancy operational delivery experience at the project, portfolio and asset level. His specific expertise lies in oncology and the development of assets for rare diseases. He has led the successful build-out of Real-World Evidence Solutions Consultancy and Medical Affairs businesses within the CRO environment, building innovative RWD/RWE solutions to drive value creation across the lifecycle management. Mike joined Parexel in February of 2024 to lead the global RWR organisation and is accountable for growth and strategy, RWD/RWE solution design, epidemiology, COA sciences and sensor solutions, Scientific Data Organisation (data partnerships, insights, next generation data solutions etc.), real-world research operational delivery and excellence and thought leadership.

Message Presenter
Brad Cunningham, Verana Health

Brad Cunningham, Head of Strategic Partnerships, Verana Health

Brad Cunningham is Verana Health’s Head of Partnerships. With over eight years of experience in the Real-World-Data (RWD) space, he has specialized in leading partnerships, corporate development and strategy functions. Brad’s relationships across the digital health industry have helped fuel unique partnerships, bidirectional revenue generation and organic & inorganic strategic investments. He’s passionate about bringing the right partners, data platforms and technology to the table to solve complex questions impacting today’s patients.

Message Presenter

Who Should Attend?

This webinar will appeal to senior professionals in pharmaceutical, biotechnology and clinical research organizations, especially those in the following fields:

  • Biotech
  • Clinical Trials
  • Medical Device
  • Life Science
  • Commercialization & HEOR
  • Drug Discovery and Development
  • Patient Recruitment & Retention
  • Pharma
  • Pharmacovigilance
  • Clinical Research
  • Clinical Development
  • Data Science
  • Medical Affairs
  • Health Economics & Outcomes Research (HEOR)
  • Commercialization

What You Will Learn

Attendees will gain insights into:

  • The benefits and limitations of RWD sources such as claims, EHRs, images and genomic data
  • The value of linking RWD sources to drive decision making across the drug development lifecycle
  • How life sciences organizations have leveraged linking data sources to drive business decisions through case studies

Xtalks Partner

Verana Health®

Verana Health® is a digital health company revolutionizing patient care and clinical research by utilizing physician expertise and artificial intelligence to unlock the true potential of real-world data. With exclusive access to the world’s largest patient data sources in ophthalmology, urology and neurology, Verana Health is powering real-world evidence generation. Clinicians utilize these insights to improve the quality of care and quality of life for patients, and life sciences companies rely on the insights to accelerate the development of new therapies. For more information, visit www.veranahealth.com.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account